Bio Farma Competitors and Similar CompaniesClear all
Alumis's competitors and similar companies include Walvax Biotechnology.
 Alumis Alumis (formerly known as Esker Therapeutics) is a clinical-stage biopharmaceutical company developing oral therapies. |  Walvax Biotechnology Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs. | |
Founding Date | Founding Date 2021 | Founding Date 2001 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Francisco, US HQ | Locations Kunming, CN HQ |
Employees | Employees 107 | Employees 2,388 |
Valuation ($) | Valuation ($) 652.3 m | Valuation ($) 3.3 b |
Financial | ||
Revenue (est.) | Revenue (est.) $24.1m (FY, 2025) | Revenue (est.) ¥2.4b (FY, 2025) |
Net income | Net income ($243.3m) (FY, 2025) | Net income ¥125.2m (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 270m | Total funding raised $ 72.8m |
For sources of this data, please see the company profile
View Company Profiles
Walvax Biotechnology
HQ
Kunming, CN
Employees
2,388
Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs.
View company